Erika Jones
Senior Vice President Finance
Professional Overview
Erika Jones is an accomplished finance executive with over 15 years of experience driving strategic growth and operational excellence within the biopharmaceutical industry. As the Senior Vice President of Finance at Black Diamond Therapeutics, she leads a team responsible for all financial planning, analysis, and reporting functions to support the company's rapidly expanding pipeline of innovative cancer treatments.
Experience Summary
Current Role
In her current role as Senior Vice President of Finance at Black Diamond Therapeutics, Erika is instrumental in ensuring the company's long-term financial stability and profitability. She oversees all budgeting, forecasting, and performance management activities, while also playing a key strategic role in capital raising, mergers and acquisitions, and other high-impact initiatives. Under Erika's leadership, Black Diamond has achieved significant operational efficiencies and consistently exceeded its financial targets.
Career Progression
Erika's finance career began at EY, where she gained valuable experience as an Auditor and Advisory Services Consultant, serving clients across the healthcare and life sciences sectors. She then transitioned to industry, holding progressively senior roles at Axcella and Black Diamond Therapeutics. Erika's proven track record of driving transformative change, streamlining processes, and delivering sustainable financial performance has been instrumental in her rapid advancement to her current position as Senior Vice President of Finance.
Academic Background
Erika holds a Master of Business Administration from Miami University, where she also served as a Graduate Assistant. She earned her Bachelor of Science in Accounting, graduating cum laude.
Areas of Expertise
- Financial planning, analysis, and reporting
- Capital raising and funding strategy
- Mergers, acquisitions, and integration
- Process improvement and operational optimization
- Cross-functional collaboration and leadership
Professional Impact
As a key member of Black Diamond's executive team, Erika has played a pivotal role in securing over $500 million in funding to accelerate the development of the company's oncology pipeline. She has also led the implementation of advanced financial systems and data analytics, enabling the organization to make more informed, data-driven decisions. Erika's contributions have been instrumental in positioning Black Diamond as a leader in the highly competitive biopharmaceutical industry.
Conclusion
With her exceptional finance expertise, strategic mindset, and proven track record of driving operational excellence, Erika Jones is poised to continue making a lasting impact on Black Diamond Therapeutics and the broader life sciences sector. Her unwavering commitment to financial stewardship and organizational growth make her a valuable asset to any organization seeking to achieve sustained, profitable expansion.